Fig. 2
From: The importance of critically short telomere in myelodysplastic syndrome
A Progression-free survival (PFS) in MDS patients with shortest TL < 0.787 kb vs. with shortest TL ≥ 0.787 kb (median PFS = 16.3 months vs. not reached [NR], p = 0.0577) and B Overall survival in MDS patients with shortest TL < 0.787 kb vs. with shortest TL ≥ 0.787 kb (median OS = 22.43 months, vs. NR, p = 0.0056)